Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
Price:
23.3 CNY
0.22%
Market Closed
Updated:
May 28, 2024
Balance Sheet
Balance Sheet Decomposition
Shanghai Fosun Pharmaceutical Group Co Ltd
Shanghai Fosun Pharmaceutical Group Co Ltd
| Current Assets | 33.8B |
| Cash & Short-Term Investments | 15.3B |
| Receivables | 9.7B |
| Other Current Assets | 8.8B |
| Non-Current Assets | 79.7B |
| Long-Term Investments | 25B |
| PP&E | 23.7B |
| Intangibles | 28.2B |
| Other Non-Current Assets | 2.8B |
| Current Liabilities | 33.8B |
| Accounts Payable | 5.5B |
| Accrued Liabilities | 2.3B |
| Short-Term Debt | 15.8B |
| Other Current Liabilities | 10.1B |
| Non-Current Liabilities | 34B |
| Long-Term Debt | 15.9B |
| Other Non-Current Liabilities | 18.1B |
Balance Sheet
Shanghai Fosun Pharmaceutical Group Co Ltd
Shanghai Fosun Pharmaceutical Group Co Ltd
Currency: CNY
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
3 696
|
4 029
|
5 996
|
7 249
|
8 547
|
9 533
|
9 962
|
9 341
|
11 170
|
9 502
|
|
| Cash |
3
|
2
|
2
|
4
|
3
|
3
|
2
|
2
|
11 170
|
9 502
|
|
| Cash Equivalents |
3 693
|
4 027
|
5 994
|
7 245
|
8 544
|
9 530
|
9 960
|
9 339
|
0
|
0
|
|
| Short-Term Investments |
34
|
102
|
48
|
219
|
616
|
457
|
1 970
|
4 241
|
5 767
|
5 824
|
|
| Total Receivables |
2 191
|
2 357
|
2 762
|
4 530
|
5 048
|
5 947
|
6 376
|
8 037
|
9 135
|
9 697
|
|
| Accounts Receivables |
1 504
|
1 736
|
1 965
|
3 248
|
3 624
|
4 368
|
4 565
|
6 029
|
7 588
|
7 790
|
|
| Other Receivables |
687
|
621
|
797
|
1 282
|
1 424
|
1 579
|
1 811
|
2 007
|
1 546
|
1 908
|
|
| Inventory |
1 605
|
1 649
|
1 671
|
2 751
|
3 287
|
3 941
|
5 163
|
5 472
|
6 882
|
7 538
|
|
| Other Current Assets |
1 140
|
190
|
288
|
307
|
503
|
526
|
1 614
|
3 333
|
2 325
|
1 231
|
|
| Total Current Assets |
8 664
|
8 325
|
10 764
|
15 056
|
18 002
|
20 403
|
25 085
|
30 425
|
35 279
|
33 793
|
|
| PP&E Net |
5 839
|
5 915
|
6 386
|
8 413
|
9 374
|
11 430
|
13 258
|
14 445
|
17 395
|
23 671
|
|
| PP&E Gross |
5 839
|
5 915
|
6 386
|
8 413
|
9 374
|
11 430
|
13 258
|
14 445
|
17 395
|
23 671
|
|
| Accumulated Depreciation |
2 165
|
2 593
|
3 048
|
4 000
|
4 436
|
6 086
|
6 950
|
7 449
|
8 937
|
12 127
|
|
| Intangible Assets |
2 912
|
3 246
|
3 651
|
8 275
|
9 192
|
10 966
|
11 499
|
13 433
|
15 925
|
17 378
|
|
| Goodwill |
3 255
|
3 303
|
3 473
|
8 464
|
8 854
|
9 014
|
8 677
|
9 400
|
10 337
|
10 852
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
189
|
77
|
213
|
282
|
|
| Long-Term Investments |
14 405
|
17 234
|
18 850
|
21 124
|
24 060
|
23 021
|
23 771
|
23 920
|
25 549
|
25 012
|
|
| Other Long-Term Assets |
261
|
178
|
644
|
639
|
1 070
|
1 286
|
1 207
|
1 594
|
2 465
|
2 482
|
|
| Other Assets |
3 255
|
3 303
|
3 473
|
8 464
|
8 854
|
9 014
|
8 677
|
9 400
|
10 337
|
10 852
|
|
| Total Assets |
35 336
N/A
|
38 202
+8%
|
43 768
+15%
|
61 971
+42%
|
70 551
+14%
|
76 120
+8%
|
83 686
+10%
|
93 294
+11%
|
107 164
+15%
|
113 470
+6%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
834
|
973
|
1 025
|
1 652
|
2 184
|
2 153
|
2 942
|
4 515
|
5 426
|
5 507
|
|
| Accrued Liabilities |
590
|
614
|
751
|
875
|
1 025
|
978
|
1 132
|
1 511
|
1 885
|
2 332
|
|
| Short-Term Debt |
3 911
|
5 547
|
4 451
|
9 845
|
5 756
|
6 603
|
8 656
|
11 747
|
13 274
|
15 836
|
|
| Current Portion of Long-Term Debt |
1 110
|
1 862
|
1 824
|
763
|
4 930
|
2 562
|
6 922
|
5 127
|
5 414
|
4 752
|
|
| Other Current Liabilities |
3 093
|
1 943
|
2 058
|
3 466
|
4 029
|
5 138
|
5 220
|
6 408
|
7 299
|
5 330
|
|
| Total Current Liabilities |
9 537
|
10 939
|
10 109
|
16 600
|
17 923
|
17 434
|
24 872
|
29 310
|
33 298
|
33 758
|
|
| Long-Term Debt |
3 878
|
3 589
|
5 580
|
9 819
|
12 689
|
12 987
|
9 335
|
9 905
|
13 037
|
15 891
|
|
| Deferred Income Tax |
1 929
|
1 845
|
1 786
|
2 981
|
2 908
|
2 994
|
2 853
|
3 130
|
3 363
|
3 445
|
|
| Minority Interest |
2 428
|
2 488
|
3 060
|
4 415
|
5 615
|
7 316
|
8 989
|
9 184
|
9 526
|
10 931
|
|
| Other Liabilities |
888
|
1 159
|
1 043
|
2 829
|
3 438
|
3 501
|
641
|
2 574
|
3 357
|
3 760
|
|
| Total Liabilities |
18 661
N/A
|
20 020
+7%
|
21 578
+8%
|
36 644
+70%
|
42 574
+16%
|
44 232
+4%
|
46 690
+6%
|
54 102
+16%
|
62 581
+16%
|
67 785
+8%
|
|
| Equity | |||||||||||
| Common Stock |
2 312
|
2 314
|
2 415
|
2 495
|
2 563
|
2 563
|
2 563
|
2 563
|
2 672
|
2 672
|
|
| Retained Earnings |
7 119
|
8 932
|
11 115
|
13 367
|
15 147
|
17 650
|
20 234
|
23 866
|
26 170
|
27 501
|
|
| Additional Paid In Capital |
6 147
|
6 060
|
7 858
|
9 078
|
10 545
|
12 144
|
15 133
|
14 029
|
16 992
|
16 853
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
114
|
19
|
237
|
|
| Treasury Stock |
24
|
43
|
27
|
10
|
2
|
0
|
0
|
0
|
53
|
42
|
|
| Other Equity |
1 120
|
919
|
830
|
396
|
275
|
468
|
934
|
1 380
|
1 180
|
1 063
|
|
| Total Equity |
16 675
N/A
|
18 182
+9%
|
22 190
+22%
|
25 327
+14%
|
27 978
+10%
|
31 888
+14%
|
36 996
+16%
|
39 192
+6%
|
44 582
+14%
|
45 685
+2%
|
|
| Total Liabilities & Equity |
35 336
N/A
|
38 202
+8%
|
43 768
+15%
|
61 971
+42%
|
70 551
+14%
|
76 120
+8%
|
83 686
+10%
|
93 294
+11%
|
107 164
+15%
|
113 470
+6%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
2 314
|
2 314
|
2 415
|
2 495
|
2 563
|
2 563
|
2 563
|
2 563
|
2 670
|
2 670
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
